Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements

SIMPLE SUMMARY: Breast cancer remains the fourth-leading cause of death worldwide, and therapeutic improvement is warranted. The phosphatidylinositol 3-kinase (PI3K) pathway is one of the major pathways in oncogenesis, and PI3K alterations are common in all breast cancer subtypes. Despite modest cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertucci, Alexandre, Bertucci, François, Gonçalves, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001361/
https://www.ncbi.nlm.nih.gov/pubmed/36900211
http://dx.doi.org/10.3390/cancers15051416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001361/
https://www.ncbi.nlm.nih.gov/pubmed/36900211
http://dx.doi.org/10.3390/cancers15051416

Ejemplares similares